Octreotide and urinary glycosaminoglycan in Graves' disease.-Reference-Cited by-同舟云学术

Octreotide and urinary glycosaminoglycan in Graves' disease.

Published:1992-05-30 Issue:6839 Volume:304 Page:1444-1444
ISSN:0959-8138
Container-title:BMJ
language:en
Short-container-title:BMJ

Author:

Chang T. C.,Yao W. C.,Chang C. C.

Publisher

BMJ

Subject

General Earth and Planetary Sciences,General Environmental Science,General Engineering

Reference11 articles.

1. Octreotide and Graves' ophthalmopathy and pretibial myxoedema;Chang, T.C.; Kao, S.C.S.; Huang, K.M.;BMJ,1992

2. Octreotide and Graves';Perros, P.; James, R.A.; Kendall-Taylor, P.;ophthalmopathy. BMJ,1992

3. Somatomedin C in pathogenesis of malignant exophthalmos of endocrine origin;Hansson, H.A.; Petruson, B.; Skottner, A.;Lancet,1986

4. Glycosaminoglycan and exophthalmos;O'Brien, J.F.,1984

5. Urinary glycosaminoglycans in Graves';Kahaly, G.; Schuler, M.; Sewell, A.C.; Bernhard, G.; Beyer, J.; Krause, U.;ophthalmopathy. Clin Endocrinol,1990

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Somatostatin Analogs in Clinical Practice: A Review;International Journal of Molecular Sciences;2020-02-29

2. Novel treatment opportunities in Graves’ orbitopathy;Orvosi Hetilap;2014-08

3. Lanreotide treatment in a patient with interferon-associated Graves? ophthalmopathy;Graefe's Archive for Clinical and Experimental Ophthalmology;2004-09-28

4. Effects of octreotide on epidermal growth factor receptor, tissue plasminogen activator, and plasminogen activator inhibitor during intraperitoneal adhesion formation;Journal of Gastroenterology;2003-06

5. Therapy of Graves’ ophthalmopathy: a novel application of somatostatin analogues;Expert Opinion on Pharmacotherapy;2001-09